
Misook Yu
Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 878 |
| Issued Applications | 268 |
| Pending Applications | 204 |
| Abandoned Applications | 408 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4949373
[patent_doc_number] => 20080305499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Anti-Synoviolin Antibody'
[patent_app_type] => utility
[patent_app_number] => 11/631283
[patent_app_country] => US
[patent_app_date] => 2005-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11934
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20080305499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631283
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631283 | Anti-Synoviolin Antibody | Jul 3, 2005 | Abandoned |
Array
(
[id] => 4852554
[patent_doc_number] => 20080318297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Inhibition of Infiltration, and Cell Killing Agent'
[patent_app_type] => utility
[patent_app_number] => 11/630759
[patent_app_country] => US
[patent_app_date] => 2005-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10682
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318297.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630759
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630759 | Inhibition of Infiltration, and Cell Killing Agent | Jun 22, 2005 | Abandoned |
Array
(
[id] => 168432
[patent_doc_number] => 07666850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereof'
[patent_app_type] => utility
[patent_app_number] => 11/150406
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 12
[patent_no_of_words] => 6703
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666850.pdf
[firstpage_image] =>[orig_patent_app_number] => 11150406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/150406 | Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereof | Jun 8, 2005 | Issued |
| 11/146717 | Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis | Jun 6, 2005 | Abandoned |
Array
(
[id] => 4859585
[patent_doc_number] => 20080268435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Brca1 Markers'
[patent_app_type] => utility
[patent_app_number] => 11/628597
[patent_app_country] => US
[patent_app_date] => 2005-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5626
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20080268435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628597
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628597 | Brca1 Markers | Jun 5, 2005 | Abandoned |
Array
(
[id] => 5247306
[patent_doc_number] => 20070243540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Kits and Methods for Identification, Assessment, Prevention and Therapy of Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/597159
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10765
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597159
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597159 | Kits and Methods for Identification, Assessment, Prevention and Therapy of Breast Cancer | May 22, 2005 | Abandoned |
Array
(
[id] => 5069481
[patent_doc_number] => 20070190583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Predicitive biomarkers in cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/569980
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10752
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190583.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569980 | Predictive biomarkers in cancer therapy | May 11, 2005 | Issued |
Array
(
[id] => 7169871
[patent_doc_number] => 20050202517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP'
[patent_app_type] => utility
[patent_app_number] => 11/113994
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5852
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202517.pdf
[firstpage_image] =>[orig_patent_app_number] => 11113994
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/113994 | Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP | Apr 25, 2005 | Abandoned |
Array
(
[id] => 5732765
[patent_doc_number] => 20060257882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Novel polynuceotides and polypeptides encoded thereby'
[patent_app_type] => utility
[patent_app_number] => 11/112424
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55348
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11112424
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/112424 | Novel polynuceotides and polypeptides encoded thereby | Apr 20, 2005 | Abandoned |
Array
(
[id] => 5130723
[patent_doc_number] => 20070207120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6'
[patent_app_type] => utility
[patent_app_number] => 11/578533
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13027
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578533
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578533 | Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 | Apr 12, 2005 | Abandoned |
Array
(
[id] => 4880363
[patent_doc_number] => 20080153746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers'
[patent_app_type] => utility
[patent_app_number] => 11/547875
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12807
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547875 | Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers | Apr 5, 2005 | Abandoned |
Array
(
[id] => 7216837
[patent_doc_number] => 20050260210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/090331
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16696
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090331 | Use of anti-α5β1 antibodies to inhibit cancer cell proliferation | Mar 23, 2005 | Issued |
Array
(
[id] => 5814796
[patent_doc_number] => 20060084600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Human homologues of fused gene'
[patent_app_type] => utility
[patent_app_number] => 11/086960
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8040
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084600.pdf
[firstpage_image] =>[orig_patent_app_number] => 11086960
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/086960 | Human homologues of fused gene | Mar 20, 2005 | Abandoned |
Array
(
[id] => 7192873
[patent_doc_number] => 20050163750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby'
[patent_app_type] => utility
[patent_app_number] => 11/084223
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3797
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084223
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084223 | Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby | Mar 17, 2005 | Abandoned |
Array
(
[id] => 5410049
[patent_doc_number] => 20090123948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Autoantibody detection for cancer diagnostics'
[patent_app_type] => utility
[patent_app_number] => 10/592040
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7779
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592040 | Autoantibody detection for cancer diagnostics | Mar 6, 2005 | Issued |
Array
(
[id] => 7246982
[patent_doc_number] => 20050272063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Method for treating synovial sarcoma'
[patent_app_type] => utility
[patent_app_number] => 11/067231
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29206
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067231
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067231 | Method for treating synovial sarcoma | Feb 27, 2005 | Issued |
Array
(
[id] => 7004618
[patent_doc_number] => 20050169931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'EphA2 as a therapeutic target for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/063101
[patent_app_country] => US
[patent_app_date] => 2005-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5898
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11063101
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/063101 | EphA2 as a therapeutic target for cancer | Feb 21, 2005 | Abandoned |
Array
(
[id] => 6911876
[patent_doc_number] => 20050175634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction'
[patent_app_type] => utility
[patent_app_number] => 11/061996
[patent_app_country] => US
[patent_app_date] => 2005-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12416
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11061996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/061996 | Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction | Feb 20, 2005 | Abandoned |
Array
(
[id] => 359543
[patent_doc_number] => 07485422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Detection of CDX2 expression'
[patent_app_type] => utility
[patent_app_number] => 11/058778
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14340
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11058778
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/058778 | Detection of CDX2 expression | Feb 15, 2005 | Issued |
Array
(
[id] => 4651029
[patent_doc_number] => 20080038285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Method for Identifying and Quantifying of Tumour-Associated'
[patent_app_type] => utility
[patent_app_number] => 10/587876
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7692
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587876 | Method for identifying and quantifying of tumuor-associated | Jan 27, 2005 | Issued |